Leading Laboratory Testing Provider Seamlessly Handles 25X Increase in Patient Portal User Volume During COVID-19 with Auth0
BELLEVUE, Washington, December 10, 2020 (GLOBE NEWSWIRE) – Auth0, the identity platform for application teams, today announced that it provides BioReference Laboratories, Inc., an OPKO Health company and one of the leading providers of laboratory testing services in the United States, with end-to-end authentication for its patient portal, giving patients direct and secure access to their lab results and to their medical data. This was critical as COVID-19 hit and BioReference faced an increase in the number of new patient portal users – including a 25-fold increase in volume overnight – who needed a secure and easy to monitor their test results.
BioReference provides comprehensive diagnostic solutions to healthcare providers, clinics, hospitals, employers, government units, correctional facilities, medical groups, etc. The lab’s extensive menu of tests is used for the detection, diagnosis, evaluation, monitoring and treatment of diseases, including COVID-19. In recent months, BioReference has made significant investments in its B2B and B2C offerings, including digital customer solutions, direct-to-consumer solutions, telehealth and patient empowerment.
“COVID-19 has caused a seven to ten year acceleration in consumer and digital trends,” said Richard Schwabacher, senior vice president of digital health and chief digital officer at BioReference Laboratories. “Securing, transmitting and authorizing patient access to health information digitally is now essential to the practice of medicine and at the heart of what is needed in a modern digital health solution. “
Identity and Access Management (IAM) has been a key part of BioReference’s transition to a more patient-centric model. The company used Auth0 as an IAM in its new patient portal so that patients can view results and pay their bills securely, giving them direct access to their health information. Now, patients no longer have to depend on their healthcare provider to act as an intermediary to access this information.
“Auth0 helps address concerns about user safety and access, especially at times like this when COVID-19 is causing a significant increase in patient demand,” said Vinny Pacione, vice president of consumer technology and digital solutions at BioReference Laboratories. “Enabling this data to be delivered to individuals on a self-service basis using scalable and automated digital platforms was a key issue to be addressed. The most fundamental part of the solution is securing the data and ensuring that only people who have the proper authorization can access it.
“Identity management is a critical part of any digital transformation initiative, and COVID-19 has forced many businesses to transition,” said Ghazi Masood, senior vice president of the Americas for Auth0. “BioReference aspires to transform telehealth and put patients at the center of the future of medicine. We are proud to support them on their journey and to help them offer a secure and transparent experience to their patients. “
More details on Auth0’s implementation by BioReference can be found here.
About BioReference Laboratories, Inc.
BioReference provides comprehensive testing to physicians, clinics, hospitals, employers, government units, correctional facilities and medical groups. BioReference has developed and offers testing services that provide accurate, high-quality results, including molecular testing to aid in COVID-19 diagnosis and serological testing to help indicate possible exposure to COVID-19. The company is networked with the five largest health plans in the United States, operates a network of 11 laboratories, and relies on a medical staff of more than 120 physicians, Ph.D. and other clinicians and scientists from Professional level. With a leading position in the fields of genetics, women’s health, maternal-fetal medicine, oncology and urology, BioReference and its specialized laboratories, GenPath and GeneDx, are advancing the course of modern medicine. For more information visit www.bioreference.com.
Auth0 provides a platform to authenticate, authorize, and secure access to apps, devices, and users. Security and enforcement teams rely on Auth0’s simplicity, scalability, and expertise to make identity work for everyone. By protecting billions of login transactions each month, Auth0 secures identities so innovators can innovate and enables global businesses to deliver trusted and superior digital experiences to their customers around the world.
Auth0 Global Communications
Subject for Auth0
Communications from BioRéférence Laboratories